Marché mondial des médicaments parapharmaceutiques – Tendances et prévisions de l’industrie jusqu’en 2030

Analyse et taille du marché des médicaments quasi-médicaments

Le marché des médicaments parapharmaceutiques devrait connaître une croissance significative au cours de la période de prévision. L'augmentation des cas d'acné et des problèmes de peau terne stimule le marché des médicaments parapharmaceutiques. La prise de conscience s'est étendue à une plus grande échelle en raison de la pollution environnementale accrue et de la sensibilisation croissante de la population à l'hygiène bucco-dentaire et personnelle. L'utilisation élevée de produits de beauté augmente dans la population, en particulier chez les femmes.

Data Bridge Market Research analyse le taux de croissance du marché des quasi-médicaments au cours de la période de prévision 2023-2030. Le TCAC attendu du marché des quasi-médicaments a tendance à être d'environ 6 % au cours de la période de prévision mentionnée. Le marché était évalué à 102,7 milliards USD en 2022 et devrait atteindre 163,69 milliards USD d'ici 2030. En plus des informations sur le marché telles que la valeur marchande, le taux de croissance, les segments de marché, la couverture géographique, les acteurs du marché et le scénario du marché, le rapport de marché organisé par l'équipe de Data Bridge Market Research comprend également une analyse approfondie des experts, une épidémiologie des patients, une analyse du pipeline, une analyse des prix et un cadre réglementaire.

Portée et segmentation du marché des médicaments quasi-médicaments

Définition du marché

Quasi drugs are one of the two primary categories of beauty products. There is a thin line between drugs and cosmetics, that can be considered as quasi-drugs. South Korea’s health authority (HA), the Ministry of Food and Drug Safety (MFDS) has categorized them under pinpoint skin care products such as acne for skin dullness as their benefits are not as suitable like drugs. Group 1 includes items used for sanitary purposes such as sanitary pads, tampons, menstrual pads, and wet wipes for oral hygiene. Group 2 includes odour inhibitors such as toothpaste, antiperspirants, and bath products, contact lenses.

Global Quasi Drugs Market Dynamics

Drivers

• Increase in Acne Cases

Acne is the most common skin condition in the U.S., affecting around 50 million people annually. Acne usually begins in puberty and affects several adolescents and young adults. Around 85 % of people between the age group of 12 and 24 years experience at least minor acne. It is also common among adults because of increasing stress, pollution, hormonal imbalance, and among others. This factor contributes in the market growth.

Opportunities

• Rising Awareness about Personal and oral Hygiene

People are getting more and more aware of personal and oral hygiene. Good personal hygiene is essential for both health and social reasons. The social benefits associated with personal habits need to be considered. In terms of oral hygiene, caring for the teeth and practicing good oral hygiene wards off bad breath, tooth decay, gum disease, and many infections. Thus, it demands a lot of quasi drugs, which helps in the growth of the market expansion.

• Increasing Demand for Retail Pharmacies

The increase in the number of quasi drugs delivered through retail pharmacies and the rise in the number of retail pharmacies in vastly developed countries create opportunities for the market growth. Furthermore, patients choose retail pharmacies for purchasing drugs, as these are easily available.

 Restraints/Challenges

• Limited Studies and Surveys

Very limited studies and surveys are associated with the quasi drug application, hindering the market's growth. Only an insignificant amount of data are available with respect to the studies. A few studies mainly focused on groups from a single hospital wherein only a limited number of patients are observed. Thus, this hampers the growth of the market.

This quasi drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the quasi drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Quasi Drugs Market Scope

The quasi drugs market is segmented on the basis of group, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Group

• Group 1
• Group 2
• Group 3

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Quasi Drugs Market Regional Analysis/Insights

The quasi drugs market is analyzed and market size insights and trends are provided by group, distribution channel and end-user as referenced above.

The major countries covered in the quasi drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for quasi drugs market due to increased healthcare and R&D expenditure and the presence of skilled professionals.

Asia-Pacific dominates the market because of the increased general skin problems, increased awareness for quasi drugs through advertisement, and rapidly improving health care infrastructure in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Quasi Drugs Market Share Analysis

Le paysage concurrentiel du marché des quasi-médicaments fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination de l'application. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liées au marché des quasi-médicaments

Les principaux acteurs opérant sur le marché des quasi-médicaments comprennent :

• Pfizer Inc. (États-Unis)
• COSMOBEAUTY CO., LTD (Japon)
• GL Sciences Inc (Japon).
• Agence japonaise de cosmétiques Tokyo Co., LTD (Japon)
• Kindai Kagaku (Japon)
• TAE BONG CO., LTD (Corée du Sud)
• International Toiletries Co., Ltd (Japon)

SKU-56133